Yahoo Web Search

Search results

1. • 

     Boy who died at 15 to become first millennial saint in Catholic Church: What did he do?

     WJW via Yahoo News· 6 days ago

     He had also considered priesthood, his mother said, before becoming sick and dying after a battle...

2. • 

     How a genetically compatible stem cell donor could be key to a Pennsylvania mother's future

     CBS News· 1 day ago

     Stem cell transplants used to treat certain kinds of cancer can depend on your ancestry. Ethnic...

3. • Bob Asmussen | Leukemia survivor Roux doing his part to fight the disease

     The News-Gazette, Champaign-Urbana, Ill. via Yahoo News· 2 days ago

     May 28—In 2003 at age 9, Champaign's Alex Roux had a bruise on his arm that wouldn't go away. There were no other symptoms. "I wasn't fatigued or tired or anything," Roux said. He was tested ...

4. • GlycoMimetics (NASDAQ:GLYC) Now Covered by Analysts at StockNews.com

     ETF DAILY NEWS· 7 days ago

     StockNews.com assumed coverage on shares of GlycoMimetics (NASDAQ:GLYC – Free Report) in a research note released on Wednesday. The firm issued a sell rating on the biotechnology company’s stock ...

5. • Small Business - The Andalusia Star-News | The Andalusia Star-News

     The Andalusia Star-News· 6 hours ago

     A live webcast of the presentation will be available on the Events & News – Events page of Jasper's Investor Relations website. An archived replay of the presentation will ...

6. • 

     ASCO24: An early look at cancer drug study results

     BioPharma Dive via Yahoo Finance· 6 days ago

     Clinical trial abstracts posted Thursday ahead of this year’s ASCO meeting give a peek at anticipated datasets from Immunocore, Merus, J&J and Merck &...

7. • Ayala Pharmaceuticals (NASDAQ:ADXS) Coverage Initiated by Analysts at StockNews.com

     ETF DAILY NEWS· 3 days ago

     StockNews.com assumed coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research report sent to investors on Sunday morning. The firm issued a sell rating on the stock ...

8. • Swiss National Bank Trims Stake in Kura Oncology, Inc. (NASDAQ:KURA)

     ETF DAILY NEWS· 2 days ago

     Swiss National Bank trimmed its stake in Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 16.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission ...

9. • Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald

     Roanoke-Chowan News-Herald· 6 days ago

     ASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug Candidates PR Newswire SUZHOU, China and ROCKVILLE, Md., May 23, 2024 SUZHOU, China and ROCKVILLE, Md., May 23, 2024 /PRNewswire/ -- Ascentage Pharma

10. • Small Business - Salisbury Post | Salisbury Post

      The Salisbury Post· 1 day ago

      Pomerantz LLP announces that a class action lawsuit has been filed against bluebird bio, Inc. (“bluebird” or the “Company”) (NASDAQ: BLUE). Such investors are advised to contact Danielle Peyton ...